Deferasirox in pyruvate kinase deficiency

Annals of Hematology

Volumn 88, Issue 4, 2009, Pages 397-

  Deeren, Dries ^a  

^a Heilig Hartziekenhuis Roeselare Menen vzw ^*  (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DEFERASIROX; FERRITIN; GAMMA GLUTAMYLTRANSFERASE;

ABDOMINAL CRAMP; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CHOLECYSTECTOMY; DIARRHEA; ENZYME DEFICIENCY; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; FERRITIN BLOOD LEVEL; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; IRON OVERLOAD; LETTER; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PYRUVATE KINASE DEFICIENCY; SIDE EFFECT; SPLENECTOMY; WEIGHT REDUCTION;

ADULT; BENZOIC ACIDS; FEMALE; HUMANS; IRON OVERLOAD; PYRUVATE KINASE; TREATMENT OUTCOME; TRIAZOLES;

EID: 60749089983     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0610-9     Document Type: Letter

References (2)

1. Metzgeroth G, Dinter D, Schultheis B, Dorn-Beineke A, Lutz K, Leismann O et al (2008) Deferasirox in MDS patients with transfusion-caused iron overload-a phase-II study. Ann Hematol (in press). PMID:18758781
2. Zanella A, Bianchi P, Fermo E (2007) Pyruvate kinase deficiency. Haematologica 92:721-723 doi: 10.3324/haematol.11469